Search results - 21 results
COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in eight European countries in the VEBIS monitoring network- October 2023 to April 2024
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Toon Braeye; Izaak Van Evercooren; Joris Van Loenhout Source: European Centre for Disease Prevention and Control, Stockholm, Sweden, p.38 (2024) Accession Number: TQ ...
Overview of air quality measures aiming to reduce emissions from road traffic and mitigate health impact in Belgium
quality measures public health Abstract: Poor air quality is the number one environmental cause of premature death across the EU. Although great efforts have been made in the last decade to reduce air ...
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses, against hospitalisation due to COVID-19 and COVID-19 related deaths in resident ...
Epidemiology of COVID-19 mortality in Belgium from wave 1 to wave 7 (March 2020 – 11 September 2022)
surveillance of COVID-19 mortality, the observations on the first seven waves combined of the epidemic in Belgium (01/03/2020 – 11/09/2022) are as follows: Waves 66.8% of the COVID-19 deaths occurred during the ...
Surveillance of COVID-19 mortality in Belgium, epidemiology and methodology during 1st and 2nd wave (March 2020- 14 February 2021)
Coronavirus COVID-19 mortality Surveillance Abstract: This report provides epidemiological figures about the characteristics of COVID-19 deaths during the first wave (1 March 2020 until 21 June 2020), the inter ...
Excess mortality during the first and second waves of the COVID-19 epidemic in Belgium
Epidemiologic surveillance of COVID-19 deaths was accurately conducted during the epidemic and it is even likely that COVID-19 deaths were underreported during the ascending phases of excess mortality by 1,193 ...
Belgian neuromuscular diseases registry (BNMDR): Annual report 2017
was needed in 2.0%. Diagnosis was considered final (with or without genetic confirmation) in about three quarters of patients (74.6%). Further, 220 deaths were reported, of which 135 (61.4%) occurred in ...
Annual Report Belgian Cystic Fibrosis Registry 2018
Belgium had no national neonatal screening program at the time. Within the year, sixteen deaths were reported (nine of them among transplanted patients) with age at death ranging from 20.4 to 70.2 years. ...
Annual Report Belgian Cystic Fibrosis Registry 2017
the time. Within the year, six deaths were reported (two of them in transplanted patients) with age at death ranging from 11.8 to 70.4 years. Ten patients benefitted from a lung transplant, and 13.9% of ...
Annual report Belgian Cystic Fibrosis Registry 2016
national neonatal screening program so far. Within the year, eight deaths were reported (four of them in transplanted patients) with age at death ranging from 20.5 to 44.8 years while 17 patients benefitted ...